| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Taiwan | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Brazil | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | Canada | 1 | |
| #8 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Object sterilising | |
| #2 | Heterocyclic compounds | |
| #3 | Therapeutic chemical compounds | |
| #4 | Medical preparations | |
| #5 | Sugars |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yatscoff Randall W | 14 |
| #2 | Foster Robert T | 11 |
| #3 | Naicker Selvaraj | 10 |
| #4 | Koziak Joseph | 8 |
| #5 | Trepanier Daniel | 4 |
| #6 | Szweda Roman | 4 |
| #7 | Mayo Patrick Rogers | 4 |
| #8 | Abel Mark | 4 |
| #9 | Foster Robert | 3 |
| #10 | Mayo Patrick R | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2006014677A1 | Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds | |
| US6884429B2 | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |